Records

Browse every document routed through Assort Design.

Route Filters

• All
• Auto : 3
• Commercial : 16 (selected)
• Medical Affairs : 39
• R&D : 21
• Cross-Functional : 10

Madrigal Receives Positive CHMP Opinion for Resmetirom (Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis June 20, 2025 PDF Version Positive recommendation based on res

One-line summary: Madrigal's Resmetirom (Rezdiffra™) has received positive CHMP opinion for treating MASH with fibrosis, demonstrating clinical benefit in fibrosis improvement and disease resolution, with European Commission decision expected August 2025.

Citations: 5  ·  Risk: 1 High / 1 Medium / 0 Low